Quarry LP’s Immunome IMNM Stock Holding History

Quarry LP’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$117K	–	2359
2025 Q3	$117K	Buy	+10,000	New	+$99.5K	0.03%	499

Other funds holding IMNM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Quarry LP's IMNM Position: Q4 2025 in Review

Quarry LP sold out of Immunome (IMNM) in Q4 2025, closing a stake of 10,000 shares — an estimated $117K sold.

Quarry LP first reported a position in IMNM in Q3 2025 and held it in 1 quarter. The position peaked at $117K in Q3 2025. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

Quarry LP reported no remaining Immunome position as of Q4 2025 after selling out during the quarter.
Quarry LP sold 10,000 Immunome shares in Q4 2025, an estimated $117K.
Quarry LP first reported a position in Immunome in Q3 2025 and held it in 1 quarter.
Quarry LP's Immunome position peaked at $117K in Q3 2025.
182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.